drug · antibody
glenzocimab
Phase 3updated 3mo agoby Acticor Biotech SAS🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 3 (across all indications), with 4 investigational indications.
targets
Platelet glycoprotein VI
all catalysts(0)
nothing on the calendar yet
Trials studying glenzocimab
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that